TG Therapeutics | TGTX - Assets

Stock Price
27.75
Daily Change
-1.37 -4.70%
Monthly
-5.64%
Yearly
-17.16%
Q1 Forecast
28.52

TG Therapeutics reported $1.03B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AbbVie USD 133.9B 3.28B Sep/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Amgen USD 90.14B 2.24B Sep/2025
Ardelyx USD 486.17M 19.4M Sep/2025
Arrowhead Research USD 1.6B 218.89M Dec/2025
Bayer EUR 104.21B 1.03B Sep/2025
Biogen USD 29.21B 877.3M Sep/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Dynavax Technologies USD 946.51M 28.06M Sep/2025
Gilead Sciences USD 58.53B 2.81B Sep/2025
J&J USD 192.82B 573M Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
PTC Therapeutics USD 2.64B 9.54M Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
TG Therapeutics USD 1.03B 322.41M Sep/2025
Vertex Pharmaceuticals USD 24.86B 825.6M Sep/2025